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In this study, we assessed the importance of insulin-like growth factor (IGF) and epidermal
growth factor (EGF) receptor co-signaling for rat neural precursor (NP) cell proliferation and
self-renewal in the context of a developmental brain injury that is associated with cerebral
palsy. Consistent with previous studies, we found that there is an increase in the in vitro
growth of subventricular zone NPs isolated acutely after cerebral hypoxia–ischemia; how-
ever, when cultured in medium that is insufficient to stimulate the IGF type 1 receptor,
neurosphere formation and the proliferative capacity of those NPs was severely curtailed.
This reduced growth capacity could not be attributed simply to failure to survive.The growth
and self-renewal of the NPs could be restored by addition of both IGF-I and IGF-II. Since the
size of the neurosphere is predominantly due to cell proliferation we hypothesized that the
IGFs were regulating progression through the cell cycle. Analyses of cell cycle progression
revealed that IGF-1R activation together with EGFR co-signaling decreased the percentage
of cells in G1 and enhanced cell progression into S and G2. This was accompanied by
increases in expression of cyclin D1, phosphorylated histone 3, and phosphorylated Rb.
Based on these data, we conclude that coordinate signaling between the EGF receptor
and the IGF type 1 receptor is necessary for the normal proliferation of NPs as well as for
their reactive expansion after injury. These data indicate that manipulations that maintain
or amplify IGF signaling in the brain during recovery from developmental brain injuries will
enhance the production of new brain cells to improve neurological function in children who
are at risk for developing cerebral palsy.
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INTRODUCTION
Many studies over the past decade have touted the regenerative
potential of the endogenous neural precursors (NPs) of the sub-
ventricular zone (SVZ) following injury. Although encouraging,
the extent of cell replacement, both in terms of the numbers of cells
produced and the variety of cell types generated is limited. How-
ever, by understanding the mechanisms that regulate the growth
of SVZ cells, therapeutic strategies can be designed to achieve
a more significant level of regeneration after CNS injury. In an
earlier study, we used flow cytometry on SVZ cells isolated acutely
after neonatal hypoxia–ischemia (H–I) and showed that epidermal
growth factor receptor (EGFR) expression increased significantly
on primitive NPs of the SVZ during recovery from neonatal H–
I. Furthermore, we showed that pharmacologically inhibiting the
EGFR reduced the expansion of the NPs that normally occurs (1).
Despite wide acceptance that the EGF receptor is a key mito-
gen for NPs, there is increasing evidence that other ligands are
central regulators of NP cell cycle progression. Two key regula-
tors are the insulin-like growth factors (IGF-I and IGF-II). The
critical importance of IGFs for neural development was shown in
studies that produced genetically engineered mice with disrupted
IGF-I gene expression. These gene targeted mice showed profound
in utero and postnatal growth retardation (2). IGF-II knockouts
showed similar growth retardation with onset earlier during gesta-
tion and, like the IGF-1 deficient mice, showed a 40% reduction in
body mass at birth (3). Homozygous IGF-1R null mice have more
profound developmental deficits at the end of gestation, and they
do not survive beyond a few hours after birth (2).
Complementary studies using transgenic mice where IGF-I was
expressed downstream of the regulatory elements for nestin that
are specifically active in NPs (4), have provided additional insights
into the roles of IGF-I in CNS neural development. In these stud-
ies, overexpressing IGF-I increased the fraction of embryonic day
14 neuroepithelial cells in S phase by over 15% compared to wild
type animals. When these transgenic mice were analyzed post-
natally, there was a significant increase in the total number of
neurons generated accompanied by a 26% reduction in the num-
ber of apoptotic cells compared to age matched wild type animals.
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These results suggested that, in vivo, IGF-I promotes the prolifer-
ation of NPs during the genesis of the CNS and that IGF-I also
promotes survival (5).
In vitro studies on the effects of IGF-I on NPs have been some-
what contradictory. Arsenijevic et al. (6) showed that embryonic
day 14 murine striatal NPs failed to proliferate in serum free,
insulin free media even when supplemented with EGF and FGF-2.
However, upon IGF-I addition, they grew effectively and formed
neurospheres in culture. IGF-I stimulation as short as 24 h, in the
constant presence of EGF, was sufficient to produce neurospheres
comparable in number to those generated during continuous
incubation with IGF-I and EGF. This effect could not be recapit-
ulated by either a transient or continuous co-incubation of IGF-I
with FGF-2. Therefore, the authors suggested that the continuous
presence of IGF-I is not necessary for EGF-stimulated NSC prolif-
eration (6). However, the results of that study were contradictory
to those of Aberg et al. (7), who studied adult rat hippocampal
NPs (7). Aberg et al. (7) showed that upon FGF-2 pretreatment
in the presence of a low concentration of insulin [100 ng/ml], the
expression of IGF-1R increases. They described distinct prolifera-
tive effects of FGF-2 (without IGF-I addition) and IGF-I (without
FGF-2 addition) and showed that the effects were additive when
both FGF-2 and IGF-I were used together (7).
The apparent contradiction between these studies, apart from
the distinct cell types used, could be due to the presence of insulin
in the culture medium, which will activate the IGF receptor system.
As the majority of NP studies use a superphysiological concentra-
tion [25µg/ml] of insulin in the culture medium that activates
IGF-1R signal transduction, the role of IGF-1R signaling is gener-
ally unappreciated. Specifically, in postnatal NPs additional studies
are needed to assess the separate effects of IGF-1R signaling from
EGF receptor signaling. Moreover, if the IGFs increase the prolifer-
ation and survival of NPs, then it is important to evaluate the role
of the IGFs in the context of developmental brain injuries where
disturbances in IGF signaling may perturb normal brain develop-
ment or recovery from injury. Thus, the focus of this study was to
test the hypothesis that IGF-1R is necessary for the expansion of
NPs following brain injury in the presence of EGF.
MATERIALS AND METHODS
NEONATAL HYPOXIA–ISCHEMIA
All animal work was approved by the institutional animal care
and use committee guidelines of the New Jersey Medical School.
Timed pregnant Wistar rats (Charles River Laboratories, Charles
River, DE, USA) were housed on a 12 h light/dark cycle at 25°C
with Purina rodent chow (catalog #5001). Following a normal
delivery, the litter size was culled to 12 pups per litter. Neonatal
H–I was induced on postnatal day 6 (P6) rat pups [P0 as day of
birth] by a permanent right common carotid artery [CCA] cau-
terization followed by systemic hypoxia. Briefly, P6 rat pups were
anesthetized with isoflurane [5% induction and 3% maintenance]
following which a midline neck incision was made. The right CCA
was separated from the vagus nerve and ligated using a bipolar
cauterizer (Malis bipolar cauterize and bipolar cutter, Codman,
Randolph, MA, USA) at 10 V. The skin incision was sutured using
4-0 silk, and the pups were returned to the dam for 2 h. Prior to
hypoxia, the pups were pre-warmed in jars partially submerged in
a 37 C water bath for 20 min after which rat pups were subjected
to systemic hypoxia in jars with humidified 8% O2/92% N2 for
75 min. Sham-operated control animals had their right CCA sep-
arated from the vagus nerve but it was not ligated, and they were
subjected to hypoxia. Following the hypoxia, the animals were left
in the jars for 15 min at normoxia after which they were returned
to their cages.
PRIMARY NEUROSPHERE ASSAY
After 3 days of recovery from H–I, P9 pups were decapitated,
their brains removed, and neurospheres generated essentially as
previously described (8). For experiments on neurospheres from
untouched rats, P4 rat pups were used. Under aseptic conditions, a
cut was made 2 mm from the anterior pole of the brain. A second
cut was made approximately 3 mm posterior to the first cut. The
hippocampus, corpus callosum, and the meninges were removed
under the microscope. Using forceps, 12 o’clock and 3 o’clock
incisions were made, and the region enclosed between the cortex
and the ventricle containing the SVZ was removed and placed
in fresh PGM [1 mM MgCl2, 0.6% Dextrose in PBS, pH 7.3].
The tissue was mechanically dissociated using forceps and then
enzymatically by the addition of 0.05% Trypsin/EDTA at 37°C for
7 min. The trypsin was inactivated by the addition of an equal
volume of newborn calf serum, and the tissue was resuspended in
ProN media [DMEM/F12 1:1 media containing 10 ng/ml d-biotin,
25µg/ml insulin,20 nM progesterone,100µM putrescine,5 ng/ml
selenium, 50µg/ml apo-transferrin, 50µg/ml gentamycin], and
triturated in proN. The triturated suspension was passed through
a 40µM Nitex screen, and the cells were collected by centrifugation
at 200× g for 2 min and washed with ProN. The cells were counted
with 0.1% Trypan blue dye under a hemocytometer and plated at
5× 104 cells/ml in ProN media containing 25 ng/ml insulin and
supplemented with 2 ng/ml EGF, 1 ng/ml FGF-2, 15 ng/ml IGF-I,
28 ng/ml IGF-II, or combinations as stated. The cells were cultured
at 37°C in 5% CO2 incubators and fed every 2 days by remov-
ing approximately half of the media and replenishing with fresh
media.
SECONDARY NEUROSPHERE PROPAGATION
Primary neurospheres were collected from 12-well plates after
6 days in vitro and pelleted by centrifugation at 12,000 rpm
for 5 min. The neurospheres were enzymatically dissociated for
5 min at 37°C in a 0.01% trypsin/EDTA solution in GHCKS
buffer (11 mM glucose, 20 mM HEPES, 10 mM citrate, 4 mM KCl,
110 mM NaCl, and 0.002 g/l phenol red). Trypsin was inhibited
by adding 10% FBS in ProN media. For spheres that were gener-
ated for the early growth response factor-1 (EGR-1) experiment,
Accutase was used to dissociate the primary spheres. The spheres
were dissociated by trituration in ProN media using progressively
less media and smaller pipette tips. The number of viable cells
was determined in a hemocytometer via exclusion of 0.1% trypan
blue dye. The cells were plated into a plastic 12-well tissue culture
plate at a density of 5× 104 viable cells/ml in ProN media sup-
plemented with growth factors as per experimental conditions.
Cell cultures were fed every 2 days by removing approximately
half the media and replacing with an equal volume of fresh
media.
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NEUROSPHERE QUANTIFICATION
A neurosphere was defined as a free-floating cluster of at least
25µm in diameter. Prior to counting the spheres, the plates were
shaken to ensure uniform distribution of the spheres in the well.
The number of neurospheres in five random fields under 4× was
determined for each well. The total number of neurosphere pro-
ducing cells, the NPs in the population, was extrapolated from
the average number of spheres per field, area of the field, and
area of the well. The cells were plated at 5× 104 cells/ml and
at 2 ml/well in a 6-well tissue culture dish for each condition.
For neurosphere volumetric measurements, digital photographs
were captured from at least 10 neurospheres from each condition
(n= 6 SVZ per condition) and volumes calculated using IP Lab
3.6 software.
PROPIDIUM IODIDE LABELING FOR FLOW CYTOMETRY ANALYSIS OF
CELL CYCLE
Neurospheres were dissociated by enzymatic and mechanical dis-
sociation in 0.05% trypsin-EDTA, fixed in 70% ethanol, and then
stored at −20°C until analysis. Cells were incubated with RNase
1 (Sigma, St. Louis, MO, USA) for 15 min and then stained with
50 mM propidium iodide (PI). PI is a fluorescent dye that interca-
lates into DNA, thus, the DNA content of a cell correlates with
fluorescence intensity, providing a profile of cells in different
phases of the cell cycle. PI stained cells were characterized using
a Becton Dickinson FACS scan and the data acquired using Cel-
lQuest™ software (Becton Dickinson, Franklin Lakes, NJ, USA)
and analyzed using ModFit™(Verity Software House, Topsham,
ME, USA). ModFit uses a robust automatic analysis engine to
detect peak and to identify ploidy patterns that correspond to
different phases of the cell cycle.
WESTERN BLOT ANALYSES
Total cell lysates from neurospheres were washed in ice-cold PBS
and isolated in sodium dodecyl sulfate (SDS) buffer (62.5 mM
Tris–HCl, 2% SDS, 10% glycol, 50 mM DTT, 1/100 protease
inhibitor cocktail, 1 mM Na3VO4, and 1 mM NaF). Lysates were
briefly sonicated and then subjected to a protein assay (Bio-Rad,
Hercules, CA, USA). A total of 15–30µg of cell lysates were boiled
at 100°C for 5 min and resolved on 7, 10, or 4–12% mini gels by
SDS polyacrylamide gel electrophoresis (SDS-PAGE). Separated
proteins were electrotransferred to nitrocellulose membranes and
blocked in 5% milk in TBS-1% Tween buffer for 1 h at room
temperature. Membranes were incubated with primary antibod-
ies overnight at 4°C (1:500, pHistone 3; 1:5000, β-actin; 1:250
for all other antibodies). The following day, membranes were
washed 3× 5 min in TBS-1% Tween and incubated with secondary
antibodies, HRP-conjugated goat anti-mouse or goat anti-rabbit
antibodies (1:5000) for 1 h at room temperature. The detection of
HRP-conjugated secondary antibodies was performed with ECL
(Perkin Elmer, Boston, MA, USA) using the Ultra-LUM imaging
device (Claremont, CA, USA).
QUANTITATIVE REAL-TIME PCR
RNA was isolated and reverse transcribed to cDNA using the
iScript kit from Bio-Rad. Q-PCR was performed on the samples
as described in Ref. (9) using beta actin as the internal control and
with Quantitect real-time primers for EGR-1 (QT00385546).
RESULTS
THE INCREASE IN NEUROSPHERE NUMBER AND SIZE FOLLOWING
NEONATAL H–I REQUIRES EGFR ACTIVATION TOGETHER WITH IGF-I
CO-SIGNALING.
Our previous studies have demonstrated that there is an increase in
the number and size of neurospheres generated from the SVZ fol-
lowing H–I injury. This increase in neurosphere size and number
occurs in response to EGF but cannot be recapitulated by FGF-2
(1). The serum free media for SVZ NPs has superphysiological lev-
els of insulin that can activate the IGF-1R in addition to the insulin
receptor (IR). Considering the results of the studies reviewed in the
Introduction together with our data, we hypothesized that IGF-1R
is necessary for the expansion of NPs following brain injury in the
presence of EGF. Therefore, we performed experiments to evaluate
the necessity of IGF-1R signaling by lowering the insulin concen-
tration in the media, to levels that only stimulate IR, from 25µg/ml
“high” to 25 ng/ml “low” in NPs when exposed to EGF, FGF-2, or
both. We found that this manipulation reduced the number of
neurospheres that were obtained from the ipsilateral hemisphere
cultured in low insulin media compared to high insulin media in
the presence of EGF by 2.5-fold (Figure 1A). Similarly, reducing
the concentration of insulin in the medium affected the size of
neurospheres. Neurospheres produced from the ipsilateral hemi-
sphere in EGF containing “low” insulin media were 3-fold smaller
than “high” insulin media [p< 0.05] (Figures 2A,B).
As earlier studies had shown that FGF-2 promoted NP pro-
liferation, we evaluated the necessity of IGF-1R signaling in the
FGF-2-mediated response of NPs following injury. Again, lower-
ing the insulin concentration from 25µg/ml to 25 ng/ml, reduced
the number of neurospheres obtained from the ipsilateral hemi-
sphere by 3-fold in the presence of FGF-2. However, it is important
to note that the numbers of neurospheres generated in the pres-
ence of FGF-2 were significantly lower compared to EGF even
in the presence of “high” insulin levels (Figure 1B). The size of
neurospheres obtained in FGF-2-media was not different when
cultured in the presence of 25µg/ml “high” insulin or 25 ng/ml
“low” insulin media (Figures 2A,C).
We had previously shown that neurospheres grow larger in
size and number from the ipsilateral hemisphere compared to
contralateral and sham-operated control SVZ in EGF supple-
mented media (8). Interestingly, the neurospheres obtained when
grown in EGF were significantly larger even in the presence of
25 ng/ml “low” levels of insulin (Figures 1A and 2A,B). By con-
trast, there were no significant differences in neurosphere number
and size in FGF-2 supplemented media containing 25 ng/ml “low”
insulin (Figures 1B and 2A,C). These data cannot be attributed
to differences in survival as NPs maintained in low insulin and
EGF for 7 days retained the capacity to form neurospheres when
transferred to high insulin containing medium and EGF (data
not shown), and similar results are obtained using this same
experimental design with mouse NPs (9).
IGF-II IS A BETTER MITOGEN THAN IGF-I FOR GROWTH AND
SELF-RENEWAL OF NPs
Emerging data indicate that NPs express both the IGF-I receptor
as well as the insulin receptor A isoform, through which IGF-II,
but not IGF-I, signals. Therefore, to determine whether IGF-I and
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FIGURE 1 |The increase in neurosphere number after neonatal H–I
requires EGFR activation together with IGF-R co-signaling. SVZ cells were
isolated from ipsilateral (IL), contralateral (CL), and sham-operated control
(CTL) at 3-day recovery from H–I. The dissociated cells were cultured in media
containing 25µg/ml “high” insulin or 25 ng/ml “low” insulin media
supplemented with 2 ng/ml EGF (A) or 1 ng/ml FGF-2 (B) for 7 days. The
numbers of neurospheres obtained per 50,000 cells plated was counted.
*p<0.05 by MANOVA and Tukey’s post hoc tests. Data represent the mean
number of neurospheres±SEM from three experiments with six animals per
experiment.
IGF-II affect SVZ NP proliferation and self-renewal differently, we
dissociated primary rat neurospheres and cultured them to gener-
ate secondary neurospheres in 25 ng/ml “low” insulin containing
media supplemented with EGF and further supplemented with
IGF-I alone, IGF-II alone, or the combination of IGF-I and IGF-II.
IGF-I and IGF-II were used at their Kds for the IGF-1R. Supple-
menting the medium with IGF-I or IGF-II significantly increased
the number of neurospheres generated vs. “low” insulin media
with EGF. The combination of both IGF-I and IGF-II produced
even greater growth than IGF-I alone (Figure 3A). Interestingly,
IGF-II generated more (p< 0.05) neurospheres than IGF-I supple-
mented media. There was no significant increase between IGF-II
and a combination of IGF-I and IGF-II on neurosphere numbers
obtained (Figure 3A).
To establish whether these growth factors affected SVZ NP
self-renewal independently or in combination, secondary neu-
rospheres generated in 25 ng/ml “low” insulin containing media
supplemented with EGF only or with IGF-I, IGF-II, or the combi-
nation were passaged and then maintained in 25µg/ml “high”
insulin media with EGF. Interestingly, spheres grown in IGF-
II generated more tertiary spheres than spheres grown in IGF-I
(Figure 3B). The number of tertiary spheres generated from cells
exposed to IGF-I and EGF with “low” insulin was not significantly
different from those exposed to “low” insulin media containing
EGF alone in the absence of exogenous IGF-I (Figure 3B). In pre-
vious studies, we evaluated how the IGF ligands affected sphere
potentiality. Spheres that were propagated in EGF containing
medium supplemented with either IGF-I, IGF-II, or IGF-I+ IGF-
II were differentiated and stained for markers of neurons or glia.
Spheres propagated in IGF-I and EGF were rarely tripotential. By
contrast, the percentage of tripotential neurospheres was greatest
in IGF-II supplemented medium (9).
IGF-1R AND EGFR CO-STIMULATION IS NECESSARY FOR CELL CYCLE
PROGRESSION
To determine whether cooperatively stimulating the IGF and EGF
receptors was necessary for cell cycle progression, and thus the
expansion of the population in culture, we assessed cell cycle using
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FIGURE 2 | Neurospheres grow larger in the presence of IGF-R
signaling together with EGF but not FGF-2. (A) Neurospheres were
generated from ipsilateral (a–c), contralateral (d–f), and sham-operated
control (g–i) SVZ at 3-day recovery from H–I and cultured in 25µg/ml
insulin[“high” insulin proN] supplemented with 2 ng/ml EGF (a, d, g);
25 ng/ml insulin[“low” insulin] supplemented with 2 ng/ml EGF (b, e, h)
or 1 ng/ml FGF-2 (c, f, i) for 7 DIV. (B)The average number of
neurospheres obtained per 50,000 SVZ cells was quantified for EGF in
“high” and “low” insulin. (C) Quantification of the average size of
neurospheres obtained with EGF in “high” and “low” insulin from
ipsilateral (IL), contralateral (CL), and control hemispheres (CTL).
*p<0.05 by MANOVA and Tukey’s post hoc tests. Data represent
mean number/size of neurospheres+SEM from three experiments
with six animals per experiment.
flow cytometry. Secondary neurospheres were propagated for 3
DIV in “high” insulin media with EGF. The neurospheres were
then starved for 18 h and stimulated for 72 h with either “low”
insulin or “high” insulin, with or without EGF. An analysis of cells
in S, G1, and G2 phases of the cell cycle using PI showed that
there was a significant decrease in percentage of cells in G1 only
when both IGF-1R and EGFR were stimulated (Figure 4A). There
was a trend toward an increase in the proportion of cells in both
S and G2 phases in the same, “high” insulin with EGF condition
(Figures 4A,B). The variability in the number of cells found in
S and G2 phases likely reflects the rapidity with which cell tra-
verse these phases in contrast to the time a cell spends in G1,
even when normally cycling. Using NP cultures, it is impossible to
synchronize the cells to better study these shorter cell cycle phases
as for traditional 2D culture conditions.
Cell cycle progression was further analyzed using Western
blot for several key cell cycle proteins (Figure 5). These analy-
ses revealed a large increase in cyclin D1 when both IGF-1R
and EGFR were stimulated compared to “high” insulin alone
(IGF-1R stimulation) or “low” insulin with EGF (EGFR stimu-
lation). These conditions also increased levels of phosphorylated
Rb. Taken together, these results support the conclusion that IGF-
1R and EGFR cooperated to promote G1 progression through the
G1/S transition. An increase in phosphorylated histone 3 suggests
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FIGURE 3 | NPs cultured in IGF-II generate more neurospheres which
promotes their self-renewal better than spheres grown in IGF-I. SVZ
cells from control rat brains were cultured in 25µg/ml “high” insulin or
25 ng/ml “low” insulin media containing 2 ng/ml EGF supplemented with
IGF-I (15 ng/ml), IGF-II (28 ng/ml), or both. (A) Quantification of the average
number of neurospheres obtained per 50,000 SVZ cells. (B) Numbers of
tertiary neurospheres obtained upon passaging to 25 ng/ml insulin media
containing 2 ng/ml EGF. *p<0.05 by MANOVA and Tukey’s post hoc tests.
further progression into the G2 phase of the cell cycle. To further
test whether the increase in phosphorylated histone 3, and cyclin
D1 were dependent on the activation of the IGF-1R, we incubated
the cells in an IGF-1R blocking antibody, A12, to block the action
of “high” insulin or IGF-I on the IGF-1R (Figure 5). When A12
was present, both cyclin D1 and phosphorylated histone 3 levels
decreased.
EGF AND IGF-I TOGETHER INCREASE LEVELS OF EARLY GROWTH
RESPONSE FACTOR-1 (EGR-1)
EGR-1 regulates the expression of many genes including the EGF
receptor. Therefore, we hypothesized that IGF-I might induce the
expression of EGR-1 to promote EGF signaling. Neurospheres
were grown in “high” insulin medium with EGF for 6–7 days and
then passaged. The cells were then incubated in growth factor free
medium for 16 h and then stimulated with EGF alone (no insulin),
FIGURE 4 | IGF-1R activation together with EGFR co-signaling
decreases G1 that leads to a trend in cell cycle progression.
Neurospheres were cultured in “high” insulin media for 3 DIV, growth
factor deprived for 18 h and then stimulated with either “low” or “high”
insulin media with or without EGF for 72 h prior to cell cycle analysis using
propidium iodide staining and flow cytometry. G1 and G2 (A) and S phase
(B) were normalized to “low” insulin media (n=3) averaged±SEM,
*indicates significance via ANOVA with Tukey’s post hoc.
IGF-I alone (no insulin), both EGF and IGF-I (no insulin),
EGF+“high” insulin or “high” insulin. The relative expression
of EGR-1 was highest when both EGF and IGF-I were added to
the media, however, contrary to our prediction, IGF-I alone only
weakly induced EGR-1 expression (Figure 6) (Values averaged
from two independent experiments).
DISCUSSION
It has been well-established that NPs can be cultured in vitro
in the presence of EGF and/or FGF-2. Moreover, infusing these
growth factors into the ventricles increases the proliferation of
periventricular SVZ NPs (10, 11). Whereas, these two growth fac-
tors are widely viewed as necessary for neural development (10),
the importance of the IGFs has been under appreciated, despite
the fact that the IGFs are abundant in the immature brain where
IGF-I is produced by neurons and IGF-II by the choroid plexus
and meninges (12–14). Likely the IGFs have been ignored because
the culture medium used to propagate NPs has high levels of
insulin, which will stimulate IGF system receptors, thus, mask-
ing the essential roles of the IGFs and their receptors in NP cell
biology.
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FIGURE 5 | Cell cycle progression marker expression is dependent on
IGF-1R activation together with EGFR co-stimulation. Neurospheres
were cultured for 3 DIV in “high” insulin, starved for 18 h, and then
stimulated with “high” [25µg/ml] insulin or “low” [25 ng/ml] insulin, with or
without EGF (A) or with IGF-I with or without EGF (B) for 72 h. IGF-1R
blocking antibody, A12, was used to block both IGF-I and “high” insulin
stimulation of IGF-1R (B).
Our data show clearly that the expansion of SVZ NPs fol-
lowing brain injury requires EGFR and IGF-1R co-signaling.
Previously, we established that EGFR signaling is necessary for
SVZ NP expansion following brain injury by pharmacologically
inhibiting EGFR activation and effectively down-regulating the
NP expansion In vitro. Furthermore, we showed that overexpress-
ing a constitutively active EGFR within NPs was sufficient to
increase entry of these cells into the S phase of cell cycle (1).
But those studies were all conducted under conditions where
there was concurrent IGF-1R stimulation. Here, we sought to
determine the role of IGF-1R signaling in the EGF-mediated
response of SVZ NPs. To do so, we replaced the supraphysio-
logical levels of insulin [25µg/ml] in our base culture media
with a physiological concentration of insulin [25 ng/ml] that
would activate the insulin receptor but not the IGF-1R, and we
evaluated the effect of this manipulation on NP growth, sur-
vival, and self-renewal. We report that: (1) The increase in neu-
rosphere number and size that occurs in response to neonatal
H–I requires IGF-1R activation together with EGFR co-signaling;
(2) NPs cultured in IGF-II generate more neurospheres and
self-renew better than NPs grown in IGF-I; and (3) IGF-1R
activation together with EGFR co-signaling stimulates cell cycle
progression.
Reminiscent of our data, an earlier study by Lin et al. (15),
showed that a single intraventricular injection of IGF-I imme-
diately after neonatal H–I reduced the extent of damage and
increased the number of proliferating cells within the SVZ (15).
The fact that IGF-I was neuroprotective supports the view that
beneficial effects of the IGFs in the context of neonatal H–I will
extend beyond their effects on the NPs of the SVZ. For example,
Wood et al. (16) demonstrated that infusing IGF-I into neonatal rat
pups acutely after H–I increased the number of oligodendrocyte
progenitor cells (OPC) in white matter (16).
Other studies conducted on primary OPCs are informative in
helping to understand how two mitogens can promote cell cycle
progression in NPs. These studies have revealed how two essen-
tial growth factors for the early OPCs, FGF-2 and IGF-I, can work
synergistically to promote progression through cell cycle. In OPCs,
FGF-2 activates p42/p44 to reduce the levels of the Cdk inhibitor
p27 (Kip1), while IGF-I promotes the phosphorylation of GSK-3β
via PI3-kinase to jointly increase cyclin D1 accumulation within
the nucleus and to promote S phase transition. In our cell cycle
analyses, IGF-1R stimulation with insulin decreased the percent-
age of cells in G1 with a trend toward an increase in S and G2.
This correlated with an increased phosphorylation of Rb and
increased levels of cyclin D1, indicators of G1 progression and
essential for pushing cells past the G1/S transition. When IGF-1R
activation was blocked using the A12 antibody, these alterations
in cell cycle protein expression were inhibited indicating a need
for receptor co-stimulation for cell cycle progression. Thus, it is
likely that similar signal transduction mechanisms are in play in
the NPs as in the OPCs. Similar studies on mouse NPs that com-
pared NP growth when maintained in “high” insulin vs. IGF-II
showed more progenitors in the “high” insulin group, indicat-
ing that the “high” insulin stimulates more progenitors to divide
(17). Additional data are needed; however, mechanistic studies
are difficult to complete using neurospheres because of the het-
erogeneity of the cell population in a neurosphere. Recent flow
cytometry studies indicate that there are likely to be as many
as 12 different NPs within a medium-sized neurosphere (18).
This heterogeneity likely contributed to the failure to achieve a
significant effect in the proportion of cells in S phase between
groups.
Cross-talk between IGF-1R and EGFR has been reported in
breast, lung, and prostate cancer cells (19, 20) as well as in COS
cells (21),which has stimulated interest in understanding the coop-
erativity between these receptors. Roudabush et al. (21) showed
that activating the IGF-I receptor lead to a matrix metalloprotease-
dependent release of HB-EGF that caused EGFR transactivation.
The transactivated EGFR accounted for IGF-I-stimulated recruit-
ment of adaptor molecules such as Shc, Grb2, SOS, and the
subsequent activation of the Ras/Raf/MEK/ERK signaling path-
way (21). Similar signaling was implicated in the studies by Jones
et al. (19). They reported that the initial growth arrest produced
by an EGFR inhibitor gefinitib (ZD 1839; IRESSA) was lost
within months of therapy in breast and prostate cell lines. The
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FIGURE 6 | EGF strongly induces EGR-1 expression in neural precursors.
Primary neurospheres were generated from P4–5 pups in standard medium.
After passaging, the cells were shifted to medium containing “High” insulin
(25µg/ml), EGF (2 ng/ml)+“high” insulin, EGF (2 ng/ml)+no insulin, IGF-I
(15 ng/ml)+ no insulin, or EGF (2 ng/ml)+ IGF-I (15 ng/ml). Cells were grown
for 6–7 days, whereupon total RNA was isolated and relative levels of EGR-1
mRNA measured by QRT-PCR. Values are the averages of two independent
experiments.
acquired resistance to the drug was due to the formation of hybrid
EGFR/IGF-1R receptors (19). Riedemann et al. (20) showed direct
hybrid dimerization between the two receptors using reciprocal
co-immunoprecipitation (20).
This study, together with our earlier studies, demonstrates that
IGF signaling is important for the expansion of NPs observed
after injury in response to EGF. NPs express both the IGF-1R
and IR-A and our studies here on rat NPs and earlier studies
on mouse NPs show that antagonizing the IGF-1R inhibits the
growth of NPs (9). Additionally, IGF-1R stimulation with insulin
results in neurospheres that contain more progenitors compared
to ones cultured with IGF-II (17). We demonstrate that more neu-
rospheres are generated in EGF containing media supplemented
with IGF-II compared to IGF-I. While a combination of IGF-I
and IGF-II is able to recapitulate the growth observed in “high”
insulin media, our collective results from this paper and previous
studies indicate that the spheres produced under these two sets of
growth conditions are not comprised of the same cell populations
as IGF-II exerts effects beyond those of IGF-1. Co-stimulation of
EGFR and IGF-1R result in the “typical” growth that is observed
in neurosphere cultures.
In a recent paper, Scafidi et al. (22) showed that stimulating
the EGFR through intranasal heparin-binding EGF administra-
tion was both neuroprotection and pro-regenerative in that it
enhanced the generation of new oligodendrocytes from progeni-
tors and promoted functional recovery (22). They concluded that
stimulating the EGFR in oligodendrocyte progenitors at a spe-
cific time after injury was a clinically viable treatment for babies
born prematurely and who sustain white matter injury. How-
ever, their studies were conducted under conditions where the
IGF-1R was activated. Though their results were impressive, it is
possible that an even better outcome could have been achieved
by also stimulating the IGF-1R. Thus, understanding the coor-
dinated signaling between IGFs and EGFs may be essential to
establish a robust regenerative response from SVZ NPs following
brain injury.
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